Hong Kong Investment Corporation

Hong Kong Investment Corporation (HKIC) is a government-owned investment company established by the Hong Kong SAR to manage strategic funds including the Hong Kong Growth Portfolio and the Strategic Tech Fund. With an initial capital of HK$62 billion, the corporation focuses on investing in industries of strategic importance, specifically life sciences, artificial intelligence, and green technology. HKIC acts as a strategic partner to high-growth companies, providing capital to foster the innovation and technology ecosystem in Hong Kong and the Greater Bay Area. In the healthcare sector, the corporation prioritizes investments in AI-driven drug discovery and biotechnology platforms to enhance regional medical innovation. The entity is designed to attract global talent and enterprises to Hong Kong while supporting the commercialization of local research and development. By leveraging its unique position, HKIC aims to drive the long-term economic development and competitiveness of Hong Kong as an international biotech hub.